Rezdiffra (resmetirom): FDA Approves First Treatment for Liver Scarring Due to Fatty Liver Disease 
Rezdiffra (resmetirom) has been approved by the FDA of the USA for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH)...........
#fattyliver #FDA #liverdisease #nonalcoholicfattyliver #Resmetirom #Rezdiffra
SCIEU Team

https://www.scientificeuropean.co.uk/medicine/rezdiffra-resmetirom-fda-approves-first-treatment-for-liver-scarring-due-to-fatty-liver-disease/